NL300391I2 - Een verzwakt Japanse encefalitus-virus aangepast aan Vero-cellen en een Japanse encefalitis vaccin - Google Patents
Een verzwakt Japanse encefalitus-virus aangepast aan Vero-cellen en een Japanse encefalitis vaccinInfo
- Publication number
- NL300391I2 NL300391I2 NL300391C NL300391C NL300391I2 NL 300391 I2 NL300391 I2 NL 300391I2 NL 300391 C NL300391 C NL 300391C NL 300391 C NL300391 C NL 300391C NL 300391 I2 NL300391 I2 NL 300391I2
- Authority
- NL
- Netherlands
- Prior art keywords
- japanese encephalitis
- weakened
- vero cells
- vaccine
- virus adapted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
- C12N2770/24151—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR19970042002 | 1997-08-28 | ||
| KR19970042001 | 1997-08-28 | ||
| PCT/KR1998/000259 WO1999011762A1 (en) | 1997-08-28 | 1998-08-25 | An attenuated japanese encephalitis virus adapted to vero cell and a japanese encephalitis vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NL300391I1 NL300391I1 (nl) | 2009-08-03 |
| NL300391I2 true NL300391I2 (nl) | 2009-11-02 |
Family
ID=26633032
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL300391C NL300391I2 (nl) | 1997-08-28 | 2009-06-10 | Een verzwakt Japanse encefalitus-virus aangepast aan Vero-cellen en een Japanse encefalitis vaccin |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US6309650B1 (enExample) |
| EP (2) | EP1604685B1 (enExample) |
| JP (1) | JP4161017B2 (enExample) |
| KR (1) | KR100314404B1 (enExample) |
| CN (1) | CN1142271C (enExample) |
| AU (1) | AU748730B2 (enExample) |
| CA (1) | CA2301000C (enExample) |
| DE (2) | DE122009000037I2 (enExample) |
| DK (2) | DK1604685T3 (enExample) |
| ES (2) | ES2382946T3 (enExample) |
| FR (1) | FR09C0037I2 (enExample) |
| MY (1) | MY129773A (enExample) |
| NL (1) | NL300391I2 (enExample) |
| NZ (1) | NZ503522A (enExample) |
| WO (1) | WO1999011762A1 (enExample) |
Families Citing this family (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2000083657A (ja) * | 1998-07-13 | 2000-03-28 | Chemo Sero Therapeut Res Inst | 日本脳炎ウイルスワクチン |
| CN1160454C (zh) * | 1998-10-05 | 2004-08-04 | 财团法人阪大微生物病研究会 | 用于抗日本脑炎病毒感染的灭活疫苗的增强免疫原及其生产方法 |
| ES2388909T3 (es) * | 1999-04-22 | 2012-10-19 | The United States Of America, As Represented Bythe Secretary Of Agriculture | Vacuna contra el virus del síndrome respiratorio y reproductivo porcino basada en aislado JA-142 aislada |
| WO2001076624A1 (en) * | 2000-04-07 | 2001-10-18 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | Inactivated japanese b encephalitis vaccine and process for producing the same |
| EP1416986A4 (en) * | 2001-06-29 | 2005-12-14 | Becton Dickinson Co | INTRADERMIC DISTRIBUTION OF VACCINES AND GENE THERAPEUTIC AGENTS VIA MICROCANNULE |
| JP2007068401A (ja) * | 2003-08-07 | 2007-03-22 | Chemo Sero Therapeut Res Inst | 西ナイルウイルスワクチン |
| CN1922308A (zh) * | 2004-02-23 | 2007-02-28 | 克鲁塞尔荷兰公司 | 病毒纯化方法 |
| CN100340596C (zh) * | 2004-05-20 | 2007-10-03 | 佛山市顺德区汉达精密电子科技有限公司 | 回收聚碳酸酯/丙烯腈－丁二烯－苯乙烯共聚物及其回收方法 |
| CA2602944C (en) * | 2005-04-11 | 2015-08-11 | Crucell Holland B.V. | Virus purification using ultrafiltration |
| WO2008115314A2 (en) * | 2007-01-31 | 2008-09-25 | Sanofi Pasteur Biologics Co. | Flavivirus vaccine vector against influenza virus |
| MY173418A (en) * | 2007-12-26 | 2020-01-23 | Daiichi Sankyo Co Ltd | Method of producing japanese encephalitis avccines stably storable over long time and use of the vaccine |
| CN102112153B (zh) * | 2008-06-04 | 2014-04-16 | 一般财团法人化学及血清疗法研究所 | 灭活日本脑炎病毒颗粒作为佐剂的用途 |
| WO2010013601A1 (ja) * | 2008-07-30 | 2010-02-04 | 久光製薬株式会社 | マイクロニードルデバイスおよびマイクロニードルデバイスによる日本脳炎ウイルス抗原の奏功性を上昇させる方法 |
| WO2010137036A2 (en) * | 2009-05-25 | 2010-12-02 | Panacea Biotec Ltd | Novel japanese encephalitis vaccine and method of manufacturing the same |
| KR101144993B1 (ko) * | 2009-06-18 | 2012-06-27 | 대한민국 | 돼지 일본뇌염 바이러스의 고농축 혈구응집용 항원 |
| DK2788023T3 (en) | 2011-12-06 | 2016-12-19 | Valneva Austria Gmbh | Aluminum compounds for use in therapeutics and vaccines |
| US9895437B2 (en) | 2012-04-18 | 2018-02-20 | Valneva Austria Gmbh | Aluminum compounds for use in therapeutics and vaccines |
| RU2706693C2 (ru) * | 2013-09-14 | 2019-11-20 | Бхарат Байотек Интернэшнл Лимитед | Вирусная вакцина и способы ее производства |
| CN105695424B (zh) * | 2015-04-01 | 2019-06-14 | 中国食品药品检定研究院 | 乙型脑炎减毒活疫苗株sa14-14-2在人二倍体细胞2bs上的适应株及其疫苗 |
| EP4253403A3 (en) | 2015-12-23 | 2023-12-27 | Valneva Austria GmbH | Zika virus purification |
| US10881723B2 (en) | 2016-01-15 | 2021-01-05 | Km Biologics Co., Ltd. | Vaccine containing immobilized virus particles |
| WO2017210215A1 (en) | 2016-05-31 | 2017-12-07 | The Government Of The United States Of America As Represented By The Secretary Of The Army | Zika virus vaccine and methods of production |
| SG11202001161YA (en) | 2017-09-21 | 2020-03-30 | Valneva Se | Method of producing pharmaceutical compositions comprising immunogenic chikungunya virus chikv-delta5nsp3 |
| CA3081581A1 (en) | 2017-11-03 | 2019-05-09 | Takeda Vaccines, Inc. | Method for inactivating zika virus and for determining the completeness of inactivation |
| AU2018375173B2 (en) | 2017-11-30 | 2022-08-25 | Takeda Vaccines, Inc. | Zika vaccines and immunogenic compositions, and methods of using the same |
| CN110684747B (zh) * | 2018-07-06 | 2024-05-24 | 厦门大学 | 灭活及保存呼吸道合胞病毒的方法 |
| US20210277361A1 (en) * | 2018-08-27 | 2021-09-09 | Mican Technologies Inc. | Method for evaluating anti-infective drugs, vaccines, etc. using immortalized monocytic cells and induced cells |
| WO2021178306A1 (en) | 2020-03-01 | 2021-09-10 | Dynavax Technologies Corporation | Coronavirus vaccines comprising a tlr9 agonist |
| EP3895729A1 (en) | 2020-03-01 | 2021-10-20 | Valneva Austria GmbH | Cpg-adjuvanted sars-cov-2 virus vaccine |
| WO2021176434A1 (en) | 2020-03-01 | 2021-09-10 | Valneva Austria Gmbh | Cpg-adjuvanted sars-cov-2 virus vaccine |
| WO2021204825A2 (en) | 2020-04-06 | 2021-10-14 | Valneva Austria Gmbh | INACTIVATED SARS-CoV-2 VIRUS VACCINE |
| WO2023148256A1 (en) | 2022-02-02 | 2023-08-10 | Valneva Austria Gmbh | Inactivated sars-cov-2 virus vaccine |
| EP4428231A4 (en) * | 2022-04-20 | 2025-11-19 | Korea Nat Institute Of Health | GENOTYPE 5 OF HIGH-TIRES JAPANESE ENCEPHALITIS VIRUS AND ITS USE |
| EP4652265A1 (en) | 2023-01-18 | 2025-11-26 | Valneva Austria GmbH | Process for virus production in a bioreactor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2704258B2 (ja) * | 1987-10-31 | 1998-01-26 | 日本臓器製薬株式会社 | 組み換えワクチニアウイルス |
| GB8821656D0 (en) * | 1988-09-15 | 1988-10-12 | Health Lab Service Board | Pharmaceutical compositions for eliciting immunostimulant effect |
| JPH085803B2 (ja) * | 1988-11-10 | 1996-01-24 | 武田薬品工業株式会社 | 日本脳炎ワクチンの製造法 |
| EP0562136A1 (en) * | 1992-03-24 | 1993-09-29 | Division Of Microbiology, Kyoto Biken Laboratories, Inc. | Live vaccine to getah virus infectious disease, and trivalent live vaccine to Japanese encephalitis virus, porcine parvovirus and getah virus infectious diseases |
| US6010894A (en) * | 1997-06-13 | 2000-01-04 | Research Development Foundation | Method of screening for attenuating viruses |
-
1998
- 1998-08-25 DK DK05014317.1T patent/DK1604685T3/da active
- 1998-08-25 EP EP05014317A patent/EP1604685B1/en not_active Expired - Lifetime
- 1998-08-25 US US09/486,392 patent/US6309650B1/en not_active Expired - Lifetime
- 1998-08-25 ES ES05014317T patent/ES2382946T3/es not_active Expired - Lifetime
- 1998-08-25 CA CA002301000A patent/CA2301000C/en not_active Expired - Lifetime
- 1998-08-25 AU AU90047/98A patent/AU748730B2/en not_active Expired
- 1998-08-25 DE DE122009000037C patent/DE122009000037I2/de active Active
- 1998-08-25 DK DK98941885T patent/DK1025209T3/da active
- 1998-08-25 ES ES98941885T patent/ES2281929T3/es not_active Expired - Lifetime
- 1998-08-25 CN CNB988097974A patent/CN1142271C/zh not_active Expired - Lifetime
- 1998-08-25 NZ NZ503522A patent/NZ503522A/en not_active IP Right Cessation
- 1998-08-25 DE DE69837211T patent/DE69837211T2/de not_active Expired - Lifetime
- 1998-08-25 JP JP2000508774A patent/JP4161017B2/ja not_active Expired - Lifetime
- 1998-08-25 EP EP98941885A patent/EP1025209B1/en not_active Expired - Lifetime
- 1998-08-25 WO PCT/KR1998/000259 patent/WO1999011762A1/en not_active Ceased
- 1998-08-26 MY MYPI98003899A patent/MY129773A/en unknown
- 1998-08-27 KR KR1019980035007A patent/KR100314404B1/ko not_active Expired - Fee Related
-
2009
- 2009-06-10 NL NL300391C patent/NL300391I2/nl unknown
- 2009-08-14 FR FR09C0037C patent/FR09C0037I2/fr active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR19990023955A (ko) | 1999-03-25 |
| WO1999011762A1 (en) | 1999-03-11 |
| ES2382946T3 (es) | 2012-06-14 |
| DE69837211D1 (de) | 2007-04-12 |
| CA2301000C (en) | 2003-07-08 |
| AU748730B2 (en) | 2002-06-13 |
| JP4161017B2 (ja) | 2008-10-08 |
| CN1142271C (zh) | 2004-03-17 |
| EP1025209B1 (en) | 2007-02-28 |
| US6309650B1 (en) | 2001-10-30 |
| DK1604685T3 (da) | 2012-06-18 |
| NZ503522A (en) | 2001-06-29 |
| DE122009000037I1 (de) | 2009-11-05 |
| DE69837211T2 (de) | 2007-12-06 |
| FR09C0037I2 (fr) | 2021-11-05 |
| EP1604685B1 (en) | 2012-02-22 |
| AU9004798A (en) | 1999-03-22 |
| KR100314404B1 (ko) | 2002-10-12 |
| CA2301000A1 (en) | 1999-03-11 |
| FR09C0037I1 (enExample) | 2009-09-25 |
| MY129773A (en) | 2007-04-30 |
| ES2281929T3 (es) | 2007-10-01 |
| NL300391I1 (nl) | 2009-08-03 |
| DK1025209T3 (da) | 2007-06-25 |
| EP1025209A1 (en) | 2000-08-09 |
| EP1604685A2 (en) | 2005-12-14 |
| CN1272879A (zh) | 2000-11-08 |
| DE122009000037I2 (de) | 2011-06-16 |
| JP2001514844A (ja) | 2001-09-18 |
| EP1604685A3 (en) | 2006-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300391I2 (nl) | Een verzwakt Japanse encefalitus-virus aangepast aan Vero-cellen en een Japanse encefalitis vaccin | |
| DK0870508T3 (da) | Influenzavaccine | |
| DE69630044D1 (de) | Viren inaktivierende umhüllungen | |
| NL300379I2 (nl) | Bepaalde 5-alkyl-2-arylaminofenylazijnzuren en derivaten daarvan | |
| DE60018074D1 (de) | Faltbarer einweg-dosieraerosolabstandshalter und verfahren dazu | |
| ID22873A (id) | Senyawa-senyawa heterosiklik dan pemakaiannya untuk menginhibisi b-amyloid peptida | |
| NO20004104L (no) | Preparater omfattende virus og fremgangsmater for konsentrering av viruspreparater | |
| IS5433A (is) | Sýklískar amínafleiður og notkun þeirra sem lyf | |
| GB9811433D0 (en) | Virus vaccine | |
| DE69820660T2 (de) | Träger zum halten von orthodontischen brackets | |
| ID17506A (id) | Benda absorben dan metode untuk memproduksinya | |
| IS5744A (is) | Nýjar 3-arýl-própíónsýruafleiður og -hliðstæður | |
| IT1317988B1 (it) | Procedimento e dispositivo per produrre depressione in un veicolo | |
| EP1037974A4 (en) | TRUNCATED PROTEIN OF HEPATITIS C VIRUS NS5B AND RELATED METHODS OF IDENTIFYING ANTIVIRAL COMPOUNDS | |
| HUP0104881A3 (en) | Method to produce inactivated w/o emulsion adjuvated vaccines | |
| EP0711310A4 (en) | Human antibodies against varicella-zoster virus | |
| DE69826593D1 (de) | Neospora Impstoff | |
| GB9713979D0 (en) | Method for attaching peg to macromolecules | |
| DE69822542D1 (de) | Verkapslung einer Untereinheit des Bovinen Herpes Virus Typ-1 in wässrigen Lösungsmitteln als Impfstoff. | |
| EP0769952A4 (en) | VACCINE AGAINST THE INFECTIOUS CHICKEN ANEMIA VIRUS | |
| ATE240392T1 (de) | Spezifische oligonukleotide fuer hepatitis c- virus | |
| PT841943E (pt) | Virus herpeticos avirulentos uteis como agentes tumoricidas e vacinas | |
| HU9702540D0 (en) | Carrying matherial for virus vaccine administered in intranasal way and virus vaccine itself | |
| HU0400424D0 (en) | Hepatitis virus vaccines | |
| DE60024406D1 (de) | Fischsosse und Verfahren zu deren Herstellung |